Table 4 Dogs having a complete clinical response followed by a relapse before 6 months
From: RNA disruption indicates CHOP therapy efficacy in canine lymphoma
Dog | Phenotype | Relapse (months) | Time (weeks) from Start of Treatment | Clinical Response | RDI Value |
|---|---|---|---|---|---|
CL1–14 | Unknown | 5.1 | 2 3 6 10 | Not recorded CR CR CR | 0.4 0.3 n/a n/a |
CL1–37 | T cell | 3.7 | 2 4 10 | CR CR All WNL except pop mildly enlarged L 2 and R 1.5 | 0.3 n/a 0.4 |
CL1–39 | T cell | 3.2 | 2 5 10 | CR CR CR | 0.8 0.9 1.4 |